Corticotropin-stimulated steroid profiles to predict shock development and mortality in sepsis: From the HYPRESS study - Université de Versailles Saint-Quentin-en-Yvelines Access content directly
Journal Articles Critical Care Year : 2022

Corticotropin-stimulated steroid profiles to predict shock development and mortality in sepsis: From the HYPRESS study

Josef Briegel
  • Function : Author
  • PersonId : 1376891
Patrick Möhnle
  • Function : Author
Didier Keh
  • Function : Author
Johanna M Lindner
  • Function : Author
Anna C Vetter
  • Function : Author
Holger Bogatsch
  • Function : Author
Dorothea Lange
  • Function : Author
Sandra Frank
  • Function : Author
Ludwig C Hinske
  • Function : Author
Michael Vogeser
  • Function : Author
Michael Bauer
  • Function : Author
Thorsten Brenner
  • Function : Author
Patrick Meybohm
  • Function : Author
Markus Weigand
  • Function : Author
Matthias Gründling
  • Function : Author
Markus Löffler
  • Function : Author
Michael Kiehntopf
  • Function : Author
Frank Bloos
  • Function : Author
Gunnar Elke
  • Function : Author
Melanie Meersch-Dini
  • Function : Author
Christian Putensen
  • Function : Author
Achim Kaasch
  • Function : Author
Stefan Kluge
  • Function : Author

Abstract

Abstract Rationale Steroid profiles in combination with a corticotropin stimulation test provide information about steroidogenesis and its functional reserves in critically ill patients. Objectives We investigated whether steroid profiles before and after corticotropin stimulation can predict the risk of in-hospital death in sepsis. Methods An exploratory data analysis of a double blind, randomized trial in sepsis (HYPRESS [HYdrocortisone for PRevention of Septic Shock]) was performed. The trial included adult patients with sepsis who were not in shock and were randomly assigned to placebo or hydrocortisone treatment. Corticotropin tests were performed in patients prior to randomization and in healthy subjects. Cortisol and precursors of glucocorticoids (17-OH-progesterone, 11-desoxycortisol) and mineralocorticoids (11-desoxycorticosterone, corticosterone) were analyzed using the multi-analyte stable isotope dilution method (LC–MS/MS). Measurement results from healthy subjects were used to determine reference ranges, and those from placebo patients to predict in-hospital mortality. Measurements and main results Corticotropin tests from 180 patients and 20 volunteers were included. Compared to healthy subjects, patients with sepsis had elevated levels of 11-desoxycorticosterone and 11-desoxycortisol, consistent with activation of both glucocorticoid and mineralocorticoid pathways. After stimulation with corticotropin, the cortisol response was subnormal in 12% and the corticosterone response in 50% of sepsis patients. In placebo patients ( n = 90), a corticotropin-stimulated cortisol-to-corticosterone ratio > 32.2 predicted in-hospital mortality (AUC 0.8 CI 0.70–0.88; sensitivity 83%; and specificity 78%). This ratio also predicted risk of shock development and 90-day mortality. Conclusions In this exploratory analysis, we found that in sepsis mineralocorticoid steroidogenesis was more frequently impaired than glucocorticoid steroidogenesis. The corticotropin-stimulated cortisol-to-corticosterone ratio predicts the risk of in-hospital death. Trial registration Clinical trial registered with www.clinicaltrials.gov Identifier: NCT00670254. Registered 1 May 2008, https://clinicaltrials.gov/ct2/show/NCT00670254 .
Fichier principal
Vignette du fichier
s13054-022-04224-5.pdf (2.5 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-04552873 , version 1 (19-04-2024)

Identifiers

Cite

Josef Briegel, Patrick Möhnle, Didier Keh, Johanna M Lindner, Anna C Vetter, et al.. Corticotropin-stimulated steroid profiles to predict shock development and mortality in sepsis: From the HYPRESS study. Critical Care, 2022, 26 (1), pp.343. ⟨10.1186/s13054-022-04224-5⟩. ⟨hal-04552873⟩
1 View
2 Download

Altmetric

Share

Gmail Facebook X LinkedIn More